Investec anticipates solid FY2024 performance

Investec (LSE: INL) forecasts earnings per share to jump to 102.9p-106.8p for the year ending March 31, up from 85.8p previously. This projected increase factors in a gain from the recent merger of its UK … Read more

Prudential boasts stellar growth fueled by Asia focus

Prudential (LSE: PRU) has unveiled a stellar performance for 2023, propelled by a laser-sharp focus on Asia and Africa that yielded soaring profits and new business. The insurance giant’s annual premium equivalent (APE) sales, a … Read more

AstraZeneca bolsters cancer arsenal with $2.4 billion Fusion buy

AstraZeneca (LSE: AZN) has taken a significant step towards revamping cancer treatment with a $2.4 billion acquisition of Fusion Pharmaceuticals^, a leader in next-generation radioconjugate therapies. This strategic move reinforces AstraZeneca’s commitment to offering patients … Read more

Currys sales surprise boosts profits, shares rise

Currys (LSE: CURY) shares jumped 5% in Monday’s trading after revising its full-year profit forecast upwards. The improved outlook follows stronger-than-expected sales since the start of the year. Previously, Currys projected full-year adjusted pretax profit … Read more

Focusrite shares tumble on weak content creation market

Music equipment maker Focusrite (LSE:TUNE) saw its shares plummet 27% this morning after revealing lower-than-expected revenue forecasts. The company now expects full-year revenue to be at least £155 million, down from £178.5 million the previous … Read more